Personalising secondary prevention: different treatments for different strokes
Author:
- 4 September 2019
- journal article
- review article
- Published by BMJ in Practical Neurology
- Vol. 20 (1) , 34-38
Abstract
Stroke is a syndrome caused by many different disease mechanisms rather than being a single disease. It is important to identify the underlying mechanism accurately in individual patients in order to choose the best treatment approach. This article provides practical tips to diagnose the underlying subtype of stroke, and in particular discusses non-lacunar pathologies that can present with a clinical lacunar syndrome. It also reviews the recent advances in recurrent stroke prevention, including using more intensive antiplatelet regimens in the acute phase, and the concept that undetected cardiac arrhythmias may be important in apparently cryptogenic stroke.Keywords
This publication has 22 references indexed in Scilit:
- Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIANew England Journal of Medicine, 2018
- Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic AttackNew England Journal of Medicine, 2013
- Ischemic stroke is associated with the ABO locus: The EuroCLOT studyAnnals of Neurology, 2012
- Oxfordshire Community Stroke Project Classification Poorly Differentiates Small Cortical and Subcortical InfarctsStroke, 2011
- Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trialThe Lancet, 2006
- Recent advances in management of transient ischaemic attacks and minor ischaemic strokesThe Lancet Neurology, 2006
- Dual Antiplatelet Therapy With Clopidogrel and Aspirin in Symptomatic Carotid Stenosis Evaluated Using Doppler Embolic Signal DetectionCirculation, 2005
- A diffusion-weighted MRI study of acute ischemic distal arm paresisNeurology, 2001
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993